Sharon Fong
- Molecular Biology top 5%
- Immunology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Epidemiology top 10%
- Co-authors
- Ralph SchwallDavid A. LawrenceAvi AshkenaziHartmut KoeppenJeanine L. BussiereScot A. MarstersAndrea HebertZahra Shahrokh
- Topics
- Cell death mechanisms and regulation (5 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Cancer Research and Treatments (2 papers)
- Partner nations
- United StatesFranceCuba
In The Last Decade
Sharon Fong
11 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 2.3k
- Immunology 829
- Oncology 720
- Cancer Research 640
- Epidemiology 326
Countries citing papers authored by Sharon Fong
This map shows the geographic impact of Sharon Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Fong more than expected).
Fields of papers citing papers by Sharon Fong
This network shows the impact of papers produced by Sharon Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Fong. The network helps show where Sharon Fong may publish in the future.
Co-authorship network of co-authors of Sharon Fong
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Fong. A scholar is included among the top collaborators of Sharon Fong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Fong. Sharon Fong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 51 | |
| 3 | 49 | |
| 4 | 97 | |
| 5 | Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth. | 59 |
| 6 | 431 | |
| 7 | 65 | |
| 8 | Safety and antitumor activity of recombinant soluble Apo2 ligandbreakdown → | 1892 |
| 9 | 13 | |
| 10 | Anticuerpos monoclonales contra el antigeno carcino embrionario en ensayos inmunohistoquimicos e inmunoquimicos | 1 |
| 11 | Carcinoembryonic antigen fraction in lung cancer. | 1 |
About Sharon Fong
Sharon Fong is a scholar working on Biotechnology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 11 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (640 citations), Immunology (829 citations) and Molecular Biology (2.3k citations). Sharon Fong has collaborated with scholars based in United States, France and Cuba. Frequent co-authors include Ralph Schwall, David A. Lawrence, Avi Ashkenazi, Hartmut Koeppen, Jeanine L. Bussiere, Scot A. Marsters, Andrea Hebert, Zahra Shahrokh, Laura DeForge and Iphigenia L. Koumenis. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.